• Fill in alt tag

    PREVENA RESTOR BELLA FORM™ Incision Management System aids in incision and surrounding soft tissue management. It provides up to 14 days of negative pressure therapy with a dressing change required at 7 days.


PREVENA RESTOR™ Incision Management System benefits:

  • Aids in incision and surrounding soft tissue management

  • Delivers continuous -125mmHg up to 14 days (Dressing change required at 7 days) to the incision site

  • Reduces edema5

  • Helps hold incision edges together6

  • Creates a barrier to external contaminants8

The PREVENA RESTOR™ Incision Management System is intended to manage the environment of surgical incisions that continue to drain following sutured or stapled closure by maintaining a closed environment and removing exudate via the application of negative pressure wound therapy.


Request a complimentary product evaluation now.

  • All fields are required unless indicated optional

  •  
  • A representative will reach out to you. The product evaluation may be subject to availability of the product at your location/area.


    The information on this site is intended for healthcare professionals. Patients should consult a healthcare professional regarding specific medical conditions and treatments.


    3M takes your privacy seriously. 3M and its authorized third parties will use the information you provided in accordance with our Privacy Policy to send you communications which may include promotions, product information and service offers. Please be aware that this information may be stored on a server located in the U.S. If you do not consent to this use of your personal information, please do not use this system.

  • Submit

  • Learn more

    Download the PREVENA RESTOR BELLA FORM™ brochure for more detail and to see detailed benefits of PREVENA™ Therapy.

    DOWNLOAD BROCHURE


  • References:

    1 ) Blackburn JH II, Boemi L, Hall WW, et al. Negative-pressure dressings as a bolster for skin grafts. Ann Plast Surg. 1998;40(5):453-457.
    2) Wilkes RP, Kilpadi DV, Zhao Y, Kazala R, McNulty A. Closed Incision management with negative pressure wound therapy (CIM): biomechanics. Surg Innov. 2012 Mar;19(1):67-75.
    doi:10.1177/1553350611414920. Epub 2011 Aug 5.
    3) Kilpadi DV, Olivie M. Impact of two negative pressure incision management systems on simulated incisions in a tissue proxy at 2 time points. Presented at: Symposium on
    Advanced Wound Care/Wound Healing Society; April 13-17, 2016; Atlanta, GA.
    4) Shah A, Sumpio BJ, Tsay C, et al. Incisional negative pressure wound therapy augments perfusion and improves wound healing in a swine model pilot study. Ann Plast Surg. 2019;
    82(4S):S222-S227.
    5) Glaser DA, Farnsworth CL, Varley ES, et al. Negative pressure therapy for closed spine incisions: a pilot study. Wounds. 2012;24(11):308-316.
    6) Wilkes RP, Kilpadi DV, Zhao Y, et al. Closed Incision management with negative pressure wound therapy (CIM): biomechanics. Surg Innov. 2012;19(1):67-75.
    7) Kilpadi DV, Cunningham MR. Evaluation of closed incision management with negative pressure wound therapy (CIM): hematoma/ seroma and involvement of the lymphatic
    system. Wound Repair Regen. 2011;19(5):588-596. doi:10.1111/j.1524-475X.2011.00714.x.
    8) Payne J. Evaluation of the resistance of the Prevena incision dressing top film to viral penetration. San Antonio, TX: Kinetic Concepts, Inc.; June 19, 2009. Report No.:
    0000021109.
    † In a comparative bench study under controlled conditions
    ‡ In an animal model compared to gauze, as measured by VEGF and Factor VIII expression
    PRA-PM-US-01605


The brands listed above are trademarks of 3M.

United States - English